Darius Shahida

Darius is Chief Strategy Officer at Science Corporation. Working with CEO Max Hodak, he is responsible for helping shape and execute the company’s long-term vision of restoring, improving, and extending life. He leads strategy, capital formation, business development and strategic partnerships across the company’s vision restoration, neuro and biohybrid platforms, working to translate breakthrough science into scaled, real-world impact.

Before joining Science, Darius served as Chief Strategy Officer and Chief Business Development Officer at Butterfly Network, a company he helped take public in 2021, and where he led M&A, capital raising, business development, and corporate strategy. While at Butterfly, Darius was responsible for the launch of several of its most transformative businesses, including the company’s AI business, global health business and the formation of its advanced semiconductor business, Octiv. In 2018, while a student at Harvard Business School, Darius raised $250 million for Butterfly, the largest capital raise in the history of medical imaging. Darius also led and negotiated Butterfly’s $1.5BN enterprise value merger with Longview Acquisition Corp. and Larry Robbins, which resulted in the public listing of “BFLY” on the NYSE in 2021. Since he joined Butterfly in 2018, Darius has raised over $1 Billion in capital. He holds an MBA from Harvard Business School and a B.S from Duke University, where he studied neuroscience and behavioral economics.